基于放大内镜结合窄带成像技术评价疏肝理气法治疗肝胃不和型慢性萎缩性胃炎的临床效果

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (759 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective Evaluation of clinical efficacy of soothing liver and regulating qi in the treatment of chronic atrophic gastritis (CAG) with syndrome of disharmony of liver and stomach by narrowband imaging-magnification endoscopy technology. Methods A total of 82 CAG patients with syndrome of disharmony of liver and stomach admitted to Jiangyin Hospital of Traditional Chinese Medicine Hospital, Jiangsu Province from December 2017 to December 2020 were selected as the research subjects, according to random number table method, the patients were divided into control group and study group, with 41 cases in each group. The control group was treated with conventional Western medicine, and the study group was treated with the method of soothing liver and regulating qi on the basis of the control group. Both groups were treated for three months. The traditional Chinese medicine syndrome score and the condition of NBI-ME endoscopy grading before and after treatment were observed in the two groups, the clinical efficacy and incidence of adverse reactions were compared between the two groups. Results After treatment, the clinical efficacy of the study group was better than that in the control group (P ＜ 0.05). The traditional Chinese medicine syndrome scores in both groups were lower than those before treatment, which in the study group were lower than that in the control group (P ＜ 0.05). After treatment, the condition of NBI-ME endoscopy grading in the two groups were better than those before treatment, which in the study group was better than that in the control group (P ＜ 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion The effect of soothing liver and regulating qi in the treatment of CAG with syndrome of disharmony of liver and stomach is significant, which has certain reverse effect, safe, and reliable.

Key words： Narrowband imaging-magnification endoscopy technology Soothing liver and regulating qi Syndrome of disharmony of liver and stomach Chronic atrophic gastritis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Li TANG Yu

Cite this article:

LI Li TANG Yu. Evaluation of clinical efficacy of soothing liver and regulating qi in the treatment of chronic atrophic gastritis with syndrome of disharmony of liver and stomach based on narrowband imaging-magnification endoscopy technology#br#[J]. 中国医药导报, 2021, 18(35): 154-157.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I35/154

[1] 费芹芹，葛荣美，李云涛，等.乌梅丸方加减联合艾司奥美拉唑镁肠溶片治疗慢性萎缩性胃炎的疗效观察[J].中国医院用药评价与分析，2021，21（4）：401-404.
[2] 黄妙兴，李志坚，林沛玲，等.胃苏颗粒联合四联疗法治疗幽门螺杆菌阳性慢性萎缩性胃炎的疗效观察[J].中国医院用药评价与分析，2021，21（3）：281-284.
[3] 赵文，郭师，王同单.益气健脾汤联合西药治疗慢性萎缩性胃炎临床研究[J].新中医，2020，52（6）：14-16.
[4] 陈朝聪，蔡水苗，刘海珊.质子泵抑制剂联合抗生素治疗对Hp阳性慢性萎缩性胃炎患者血清胃泌素SIL-2R CRP水平及免疫功能的影响[J].河北医学，2020，26（3）：429-432.
[5] 柳冬兵，李莉，刘加新，等.慢性萎缩性胃炎中医证型与胃蛋白酶原及幽门螺杆菌感染相关性分析——附108例临床资料[J].江苏中医药，2021，53（3）：27-29.
[6] 臧伟广.四联疗法联合胃复春对慢性萎缩性胃炎患者血清骨桥蛋白及胃泌素的影响[J].中国医药导报，2020，17（24）：130-133.
[7] 周明霞，徐惠明.疏肝理气方治疗疣状胃炎临床疗效及对血清pgⅠ、pgⅡ及CRP表达水平的影响[J].湖北中医药大学学报，2020，22（6）：32-35.
[8] 张霁雯，吴永梅，罗酩，等.PGⅠ、PGR检测联合ME-NBI在胃癌及癌前病变诊断中的应用[J].贵州医药，2020，44（3）：353-356.
[9] 郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：361-362.
[10] 中华医学会消化病学分会.中国慢性胃炎共识意见（2017年，上海）[J].胃肠病学，2017，22（11）：670-687.
[11] 中华医学会消化内镜学分会.慢性胃炎的内镜分型分级标准及治疗的试行意见[J].中华消化内镜杂志，2004， 21（2）：77-78.
[12] 中国中西医结合学会消化系统疾病专业委员会.慢性萎缩性胃炎中西医结合诊疗共识意见（2017年）[J].中国中西医结合消化杂志，2018，26（2）：121-131.
[13] 艾春花，黄铭涵.慢性萎缩性胃炎中医证型与胃镜、胃黏膜病理及幽门螺旋杆菌感染的相关性研究[J].云南中医学院学报，2016，39（5）：57-61.
[14] 梁春耕，肖定洪.中医药治疗慢性萎缩性胃炎的研究进展[J].中国医药科学，2020，10（23）：66-68，96.
[15] 王萍，尹晓岚，张北华，等.近40年慢性萎缩性胃炎及胃癌前病变中医研究述评[J].中医杂志，2020，61（22）：1943-1947.
[16] 李海文，张伟健，许艺飞，等.肠上皮化生和胃癌发生关系的研究进展[J].中华中医药杂志，2021，36（1）：311-315.
[17] 刘田田，魏翠，周国华，等.慢性萎缩性胃炎内镜与病理学诊断的临床分析[J].临床消化病杂志，2020，32（2）：90-93.
[18] 章程，成鉴晓，巩芮宁，等.窄带成像放大内镜检查联合血清指标检测对慢性萎缩性胃炎的诊断价值[J].中国医学前沿杂志：电子版，2020，12（5）：141-144.
[19] 崔创撑，时宏，田景坤，等.ME-NBI和多层螺旋CT对早期胃癌诊断价值分析[J].现代消化及介入诊疗，2019， 24（1）：94-96.
[20] 罗高标，谭人千，凌江红.疏肝理气法治疗伴抑郁焦虑的功能性消化不良研究进展[J].辽宁中医杂志，2019， 46（6）：1338-1340.
[21] 周晓露，王健，王祚克，等.中医疏肝理气法治疗冠心病效果及对血管内皮功能、血液流变学指标的影响[J].中华中医药学刊，2019，37（1）：220-223.
[22] 朱广辉，杨琳蔚，高含佳，等.疏肝理气法联合三阶梯镇痛方案在癌痛治疗中的应用[J].辽宁中医杂志，2020， 47（3）：85-87.
[23] 任洪波，崔晶，董海燕，等.特殊形态的胃型极高分化型腺癌一例[J].中华胃肠外科杂志，2020，23（8）：804-806.
[24] 王磊，时军利，李炳庆.早期胃癌内镜特点及高危因素分析[J].中国内镜杂志，2020，26（10）：48-53.
[25] 魏晨阳，王倩.中医药治疗慢性萎缩性胃炎临床用药规律[J].中医学报，2020，35（9）：2031-2034.